Content
FDA approved for more than 25 years
Mike Anderson was just 23 when he first noticed his receding hairline. He knew male pattern baldness ran in his family. “I wasn’t surprised, but I was surprised,” he recalls with a laugh, mentioning photos of his maternal grandfather, who was already bald when he got married. Still, the early onset of his own hair loss caught him off guard.
Content
If you’re noticing the early signs of baldness, maybe you can relate — you know male pattern baldness is a distinct possibility, but part of you still thinks it won’t happen to you.
Although he wasn’t happy about losing his hair in his 20s, he didn’t do anything about it. Part of his decision was due to the time—it was the mid-’80s, and there weren’t many treatments available for male pattern baldness (Rogaine® gained approval from the U.S. Food & Drug Administration in August 1988). Another factor was the amount of money treatment options cost when they first became available.
“I was a college student,” he explains. “I didn't have any money, so if it cost more than a little bit, I wasn't going do it.” According to a 1988 New York Times article, Rogaine retailed for about $100 per month when it first came out (about the equivalent of $265 in 2024).
That would have been cost-prohibitive for many people. Although the monthly cost of Rogaine has fallen drastically (you can now get generic minoxidil for $15 a month), people may still want to skip it for financial or other reasons.
Instead, Mike chose to keep his hair short to make thinning less noticeable, though it would still be years before he fully embraced a bald head. Bald celebrities bolstered his confidence. “To be honest with you, various sports stars, like Michael Jordan, helped me get comfortable with losing my hair,” he says. “I was like, ‘Wow, he’s bald, and everybody loves him, so this can’t be too bad.’”
About 10 years later, in his early 30s, Mike finally decided to shave his head. By then, he’d come to terms with his hair loss and felt less bothered by it. “I was married to my beautiful wife,” he says, “so my confidence was already really high!”
4.5 average rating
He’s never looked back, but a shaved head requires commitment. Mike shaves his every day. — yes, every day. Once, about 15 years ago, he got curious about what his hair would look like if he let it grow back. It turns out it struck a nerve.
“My kids laughed at me, and my neighbors laughed at me — my coworkers even! They pulled me aside saying, ‘Dude, seriously, you need to just cut it.’ People were really not having it. It looked like I was wearing a hat,” he says. “My kids still bring it up. That's when I made sure to shave every day.”
What would he say to other men considering embracing their baldness and shaving their heads?
“You've just got to get past it. You’ve got to let it go. I don't think I would've ever done anything for it, like getting a hair replacement or taking something,” he says. “I wouldn’t have gone that route. Instead, I embraced it and focused on other things to feel good, like working out.”
While Mike has fully embraced his baldness over the past 30 years later, it wasn’t always easy. “When I first started losing my hair, it wasn't cool,” he says. “I was young, and I was dating. It bothered me, that's for sure.”
If you’re not ready to embrace hair loss, you have more options available than ever before. The most effective treatments to help slow or reverse hair loss are the medications finasteride and minoxidil. And remember: The “right” decision is the decision you make for yourself.
Hims & Hers has strict sourcing guidelines to ensure our content is accurate and current. We rely on peer-reviewed studies, academic research institutions, and medical associations. We strive to use primary sources and refrain from using tertiary references. See a mistake? Let us know at [email protected]!
This article is for informational purposes only and does not constitute medical advice. The information contained herein is not a substitute for and should never be relied upon for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment. Learn more about our editorial standards here.
Dr. Knox Beasley is a board certified dermatologist specializing in hair loss. He completed his undergraduate studies at the United States Military Academy at West Point, NY, and subsequently attended medical school at Tulane University School of Medicine in New Orleans, LA.
Dr. Beasley first began doing telemedicine during his dermatology residency in 2013 with the military, helping to diagnose dermatologic conditions in soldiers all over the world.
Dr. Beasley is board certified by the American Board of Dermatology, and is a Fellow of the American Academy of Dermatology.
Originally from Nashville, TN, Dr. Beasley currently lives in North Carolina and enjoys spending time outdoors (with sunscreen of course) with his wife and two children in his spare time.
Bachelor of Science, Life Sciences. United States Military Academy.
Doctor of Medicine. Tulane University School of Medicine
Dermatology Residency. San Antonio Uniformed Services Health Education Consortium
Board Certified. American Board of Dermatology
Wilson, L. M., Beasley, K. J., Sorrells, T. C., & Johnson, V. V. (2017). Congenital neurocristic cutaneous hamartoma with poliosis: A case report. Journal of cutaneous pathology, 44(11), 974–977. https://onlinelibrary.wiley.com/doi/10.1111/cup.13027
Banta, J., Beasley, K., Kobayashi, T., & Rohena, L. (2016). Encephalocraniocutaneous lipomatosis (Haberland syndrome): A mild case with bilateral cutaneous and ocular involvement. JAAD case reports, 2(2), 150–152. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867906/
Patterson, A. T., Beasley, K. J., & Kobayashi, T. T. (2016). Fibroelastolytic papulosis: histopathologic confirmation of disease spectrum variants in a single case. Journal of cutaneous pathology, 43(2), 142–147. https://onlinelibrary.wiley.com/doi/10.1111/cup.12569
Beasley, K., Panach, K., & Dominguez, A. R. (2016). Disseminated Candida tropicalis presenting with Ecthyma-Gangrenosum-like Lesions. Dermatology online journal, 22(1), 13030/qt7vg4n68j. https://pubmed.ncbi.nlm.nih.gov/26990472/
Kimes, K., Beasley, K., & Dalton, S. R. (2015). Eruptive milia and comedones during treatment with dovitinib. Dermatology online journal, 21(9), 13030/qt8kw141mb. https://pubmed.ncbi.nlm.nih.gov/26437285/
Miladi, A., Thomas, B. C., Beasley, K., & Meyerle, J. (2015). Angioimmunoblastic t-cell lymphoma presenting as purpura fulminans. Cutis, 95(2), 113–115. https://pubmed.ncbi.nlm.nih.gov/25750965/
Beasley K, Dai JM, Brown P, Lenz B, Hivnor CM. (2013). Ablative Fractional Versus Nonablative Fractional Lasers – Where Are We and How Do We Compare Differing Products?. Curr Dermatol Rep, 2, 135–143. https://idp.springer.com/authorize?response_type=cookie&client_id=springerlink&redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs13671-013-0043-0
Siami P, Beasley K, Woolen S, Zahn J. (2012). A retrospective study evaluating the efficacy and tolerability of intra-abdominal once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate cancer. UroToday Int J, June 5(3), art 26. https://www.urotoday.com/volume-5-2012/vol-5-issue-3/51132-a-retrospective-study-evaluating-the-efficacy-and-tolerability-of-intra-abdominal-once-yearly-histrelin-acetate-subcutaneous-implants-in-patients-with-advanced-prostate-cancer.html
Siami P, Beasley K. (2012). Dutasteride with As-Needed Tamsulosin in Men at Risk of Benign Prostate Hypertrophy Progression. UroToday Int J, Feb 5(1), art 93. https://www.urotoday.com/volume-5-2012/vol-5-issue-1/48691-dutasteride-with-as-needed-tamsulosin-in-men-at-risk-of-benign-prostatic-hypertrophy-progression.html